Product
Carboplatin + Cisplatin + Pemetrexed + Pembrolizumab
1 clinical trial
1 indication
Indication
Pleural mesotheliomaClinical trial
Phase II Study of Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed as Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)Status: Not yet recruiting, Estimated PCD: 2026-06-01